LANXESS signs contract to acquire Emerald Kalama Chemical

Ad hoc according to Art. 17 paragraph 1 MMVO

Cologne

Specialty chemicals company LANXESS signed an agreement to acquire US-based Emerald Kalama Chemical from affiliates of American Securities LLC. Emerald Kalama Chemical is one of the leading global manufacturers of specialty chemicals especially for the consumer segment.

Emerald Kalama employs worldwide approximately 500 employees and runs three production sites. The company reported 2020 sales of around USD 425 million and EBITDA pre exceptionals of approximately USD 90 million. Around 45 percent of its turnover is generated in North America.

The enterprise value amounts to USD 1,075 million. The transaction will be financed by LANXESS existing liquidity. Closing of the transaction is anticipated in the second half of 2021 and subject to the approval of the relevant regulatory authorities.

By acquiring Emerald Kalama Chemical, LANXESS strengthens its specialty chemical portfolio especially in the Consumer Protection segment and would materially expand into the growth markets food and animal nutrition.


Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

AD HOC

Impairment of goodwill and adjustment of at-equity book value of minority interest in Envalior

February 27, 2024
AD HOC

LANXESS adjusts expectations FY 2023; Board of Management proposes dividend reduction

November 06, 2023
AD HOC

LANXESS: Results for Q2 and FY 2023 estimated below market expectations

June 19, 2023
AD-HOC

LANXESS and Advent International establish a leading global joint venture for high-performance engineering polymers

May 31, 2022
AD-HOC

LANXESS Aktiengesellschaft: Strong start into the year – first quarter 2022 expected to exceed market expectations

April 19, 2022